While other earnings may have disappointed last week, the news was good for oil giant ConocoPhilips (NYSE: COP). In what some took as a good sign for big oil, the Houston-based company reported that third quarter net income surged 41% year over year to $3.39 per share, and that revenue also surged 52% to $70 billion. We'll see whether the good news extends to other petroleum giants scheduled to report quarterly results this week.

Analysts surveyed by Thomson Financial are looking for BP (NYSE: BP) profits to have grown 43.2% in the most recent quarter to $2.34 per share on revenue of $109.7 billion, and Chevron Corp. (NYSE: CVX) to post earnings up 39.4% to $3.25 per share on revenue of $86.8 billion. Marathon Oil Corp. (NYSE: MRO), ExxonMobil Corp. (NYSE: XOM), and Royal Dutch Shell (NYSE: RDS.A) likewise are expected to report higher net income of $2.33 per share (sales of $23.4 billion), $2.40 per share (sales of $131.4 billion), and $2.65 per share, respectively. Even Valero Energy Corp. (NYSE: VLO) is expected to post earnings slightly higher to $1.46 per share (sales of $36.4 billion), despite the effects of Hurricane Ike. Among these companies, only BP and Valero beat earnings expectations in the previous quarter. Not surprisingly, analysts on average recommend buying all except Valero, and shares of all of these companies have recently hit 52-week lows.

Monday, March 24

• Walgreen Company (NYSE: WAG) to report Q2 earnings; conference call at 8:30am.
• Tiffany & Co (NYSE: TIF) to report Q2 earnings; conference call at 8:30am.
• Glu Mobile Inc. (NASDAQ: GLUU) to hold a conference call at 5:00pm to discuss the acquisition of Superscape VR PLC (PINK: SCPDF).

Tuesday, March 25

• Jabil Circuit, Inc. (NYSE: JBL) to report Q2 earnings; conference call at 4:30pm.
• FDA Pediatric Advisory Committee at 8:00am on AstraZeneca PLC (ADR) (NYSE: AZN)'s Toprol XL, Baxter
  International, Inc. (NYSE: BAX) Brevibloc and Suprane, Novartis AG (ADR) (NYSE: NVS)'s Lotensin, GlaxoSmithKline plc (ADR) (NYSE: GSK)'s Coreg, Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP)'s Colazal, Sanofi-Aventis SA (ADR) (NYSE: SNY) 's Eloxatin, and Pfizer Inc. (NYSE: PFE)'s Celebrex.

Wednesday, March 26

• Oracle Corporation (NASDAQ: ORCL) to report Q3 earnings; conference call at 5:00pm.
• Response Genetics, Inc. (NASDAQ: RGDX) to give strategic update at 5:00pm.

Thursday, March 27

• TECO Energy, Inc. (NYSE: TE) to give updated 2008 outlook at 8:00am.
• Valeant Pharmaceuticals International (NYSE: VRX) to hold conference call at 12:00pm to review Taribavirin's Phase IIb results and the company's strategy.

Friday, March 28

• Steelcase Inc. (NYSE: SCS) to report Q4 earnings; conference call at 11:00am.
• Fed Reserve Bank St Louis: 8th Annual Conference in Columbia, MO.
• PDUFA date for QLT Inc. (USA) (NASDAQ: QLTI)'s Aczone Gel for the treatment of moderate to severe acne vulgaris.

• Tiffany & Co (NYSE: TIF) to report Q4 earnings; conference call at 8:30am. Analysts will evaluate Tiffany's holiday performance, new products and note management's comments on global diamond and jewelry trends.
• Boston Scientific Corporation (NYSE: BSX) to hold analyst meeting at 8:30am.
• Canon Inc ADR (NYSE: CAJ) to hold shareholder meeting at 10pm.

• Goldman Sachs Group Inc (NYSE: GS) to hold shareholder meeting at 9:30am.
• McCormick and Company Inc (NYSE: MKC) to report Q1 earnings; conference call at 10am. Analysts will focus on McCormick's consumer segment [largest business], but will also note industrial business line performance, new spices/ingredients and commodity costs.

• Teco Energy Inc (NYSE: TE) to provide 2007 outlook; webcast at 8am.
• Media Telecommunications & Entertainment Conference 3/28-3/29

• PDUFA date for Nastech Pharmaceutical Company Inc's (NASDAQ: NSTK) Calcitonin-Salmon Nasal Spray for Osteoporosis.

• Finish Line Inc (NASDAQ: FINL) to report Q4 earnings; conference call at 8:30am. Note that the company issued disappointing guidance earlier this month.
• CKE Restaurants Inc (NYSE: CKR), the owner of Carl's Jr. and Hardee's restaurants, to report Q4 earnings; conference call at 9am. Analysts will review the company's same store sales by restaurant chain, average lunch/dinner checks, menu changes and margins. Analysts will also evaluate management's the performance of breakfast offerings, and the company's chain expansion plan.